Alamar Biosciences, Inc. (California) (ALMR)

30.69 +0.97 (+3.26%) USD  |  NASDAQ  |  Oct 23, 16:00
30.69 0.00 (0.00%) After-Hours: 20:00
More

Alamar Biosciences Shareholders Equity (Quarterly) : 312.86M for June 30, 2026

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 312.86M
Date Value
March 31, 2026 -178.07M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Personalis, Inc. 235.16M
10X Genomics, Inc. 825.55M
Champions Oncology, Inc. 3.893M
Medpace Holdings, Inc. 584.94M
Avantor, Inc. 5.630B

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 390.98M
Total Liabilities (Quarterly) 78.12M
Debt to Equity Ratio 0.1643
Current Ratio 11.85
Net Debt Paydown Yield 0.83%